This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Arexis Ab. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Yoen Joo Kim: Innovator in Recombinant Protein Manufacturing
Introduction
Yoen Joo Kim is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the manufacturing of recombinant proteins. His innovative approach has led to the development of a unique method for producing vials that contain these valuable compositions.
Latest Patents
Yoen Joo Kim holds 1 patent for a manufacturing method directed at producing vials containing a composition comprising a recombinant protein. This patent outlines a process that includes several key steps: providing a container with the recombinant protein composition, applying a vacuum to degas the composition, and subsequently filling vials with the degassed product. This method enhances the quality and stability of the recombinant proteins, making it a valuable advancement in the field.
Career Highlights
Throughout his career, Yoen Joo Kim has worked with prominent companies in the biotechnology sector. He has been associated with Arexis AB and MedImmune Limited, where he has contributed to various projects aimed at improving biopharmaceutical manufacturing processes. His expertise in recombinant protein production has positioned him as a key player in the industry.
Collaborations
Yoen Joo Kim has collaborated with several professionals in his field, including Mingyan Cao and Mary Houchin. These collaborations have fostered innovation and have led to advancements in the methodologies used in recombinant protein production.
Conclusion
Yoen Joo Kim's contributions to the biotechnology industry, particularly through his patented manufacturing method, highlight his role as an innovator in recombinant protein production. His work continues to influence the field and improve the quality of biopharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile